Subscribe to RSS
Randomized Controlled Trials of Headache Treatments in Pregnancy: A Systematic Review
Objective Headaches affect 88% of reproductive-aged women. Yet data are limited addressing treatment of headache in pregnancy. While many women experience improvement in pregnancy, primary and secondary headaches can develop. Consequently, pregnancy is a time when headache diagnosis can influence maternal and fetal interventions. This study was aimed to summarize existing randomized control trials (RCTs) addressing headache treatment in pregnancy.
Study Design We searched PubMed, CINAHL, EMBASE, ClinicalTrials.gov, Cochrane Library, CINAHL, and SCOPUS from January 1, 1970 through June 31, 2019. Studies were eligible if they were English-language RCTs addressing treatment of headache in pregnancy. Conference abstracts and studies investigating postpartum headache were excluded. Three authors reviewed English-language RCTs addressing treatment of antepartum headache. To be included, all authors agreed each article to meet the following criteria: predefined control group, participants underwent randomization, and treatment of headache occurred in the antepartum period. If inclusion criteria were met no exclusions were made. Our systematic review registration number was CRD42019135874.
Results A total of 193 studies were reviewed. Of the three that met inclusion criteria all were small, with follow-up designed to measure pain reduction and showed statistical significance.
Conclusion Our systematic review of RCTs evaluating treatment of headache in pregnancy revealed only three studies. This paucity of data limits treatment, puts women at risk for worsening headache disorders, and delays diagnosis placing both the mother and fetus at risk for complications.
Received: 12 December 2019
Accepted: 29 January 2020
02 March 2020 (online)
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol 1991; 44 (11) 1147-1157
- 2 Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. ; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68 (05) 343-349
- 3 Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999; 39 (09) 625-632
- 4 MacGregor EA. Headache in pregnancy. Neurol Clin 2012; 30 (03) 835-866
- 5 Sances G, Granella F, Nappi RE. et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23 (03) 197-205
- 6 Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997; 17 (07) 765-769
- 7 Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache 1997; 37 (04) 203-210
- 8 Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011; 12 (04) 443-451
- 9 Ertresvåg JM, Zwart JA, Helde G, Johnsen HJ, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005; 111 (04) 233-237
- 10 Melhado EM, Maciel Jr. JA, Guerreiro CA. Headache during gestation: evaluation of 1101 women. Can J Neurol Sci 2007; 34 (02) 187-192
- 11 Simbar M, Karimian Z, Afrakhteh M, Akbarzadeh A, Kouchaki E. Increased risk of pre-eclampsia (PE) among women with the history of migraine. Clin Exp Hypertens 2010; 32 (03) 159-165
- 12 Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 2009; 338: b664
- 13 Facchinetti F, Allais G, Nappi RE. et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009; 29 (03) 286-292
- 14 Robbins MS, Farmakidis C, Dayal AK, Lipton RB. Acute headache diagnosis in pregnant women: a hospital-based study. Neurology 2015; 85 (12) 1024-1030
- 15 Croke L. Gestational hypertension and preeclampsia: a practice bulletin from ACOG. Am Fam Physician 2019; 100 (10) 649-650
- 16 Loder E, Biondi D. General principles of migraine management: the changing role of prevention. Headache 2005; 45 (Suppl. 01) S33-S47
- 17 Negro A, Delaruelle Z, Ivanova TA. et al; European Headache Federation School of Advanced Studies (EHF-SAS). Headache and pregnancy: a systematic review. J Headache Pain 2017; 18 (01) 106
- 18 Shamseer L, Moher D, Clarke M. et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 350: g7647
- 19 Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 2011; 128 (01) 305-310
- 20 Akobeng AK. Understanding randomised controlled trials. Arch Dis Child 2005; 90 (08) 840-844
- 21 Deaton A, Cartwright N. Understanding and misunderstanding randomized controlled trials. Soc Sci Med 2018; 210: 2-21
- 22 Chan AW, Tetzlaff JM, Gøtzsche PC. et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013; 346: e7586
- 23 Higgins JPT, Altman DG, Gøtzsche PC. et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
- 24 Childress KMS, Dothager C, Gavard JA, Lebovitz S, Laska C, Mostello DJ. Metoclopramide and diphenhydramine: a randomized controlled trial of a treatment for headache in pregnancy when acetaminophen alone is ineffective (MAD headache study). Am J Perinatol 2018; 35 (13) 1281-1286
- 25 Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med 1995; 57 (06) 527-535
- 26 Silva JBG, Nakamura MU, Cordeiro JA, Kulay Jr L. Acupuncture for tension-type headache in pregnancy: a prospective, randomized, controlled study. J Altern Complement Med 2013; 19 (07) A20
- 27 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 07) 1-96
- 28 Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; (24, Suppl 1): 9-160
- 29 Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders: 3rd edition. Cephalalgia 2018; 38 (Suppl. 01) 1-211
- 30 Diener HC, Tassorelli C, Dodick DW. et al. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia 2019; 39 (06) 687-710
- 31 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386 (9995): 743-800
- 32 Korucu O, Dagar S, Çorbacioglu SK, Emektar E, Cevik Y. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments. Acta Neurol Scand 2018; 138 (03) 212-218
- 33 Allen SM, Mookadam F, Cha SS, Freeman JA, Starling AJ, Mookadam M. Greater occipital nerve block for acute treatment of migraine headache: a large retrospective cohort study. J Am Board Fam Med 2018; 31 (02) 211-218